Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from JP Morgan

Dylan and Will McMahon: brothers behind the UK’s only baby milk producer

The brothers helping run Kendal Nutricare on being ‘best mates’, working with their father and tackling a US shortage

The Guardian - UK

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022

Benzinga

Here's Why Analysts Had Mixed Opinions On C3.ai Post Q4 Results

Analyst opinions remained mixed about C3.ai, Inc (NYSE:AI) following its dismal FY23 guidance despite a Q4 beat. Piper Sandler analyst Arvind Ramnani downgraded C3.ai from Overweight to Neutral and slashed the price target from $28 to $15. The re-rating reflected lackluster guidance triggered by enterprise spending softness, slower customer growth, and a dismal demand. Ramnani noted the…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Once-unthinkable: Subsidies for American oil drillers

Could the Federal government be forced to give energy giants subsidies to boost production?

Axios

Analysts Slash Price Target On American Eagle Outfitters Post Q1 Results

Analysts slashed the price target of American Eagle Outfitters Inc (NYSE:AEO) following the company's Q1 results. BMO Capital analyst Daniel Stroller lowered the price target to $15 (14% upside) from $23 and kept a Market Perform rating on the shares. Stoller noted that macro-economic problems like inflation and soaring gas prices had amplified the issues in…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Upgrades

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

Benzinga

SVB Sees De-Risked Opportunity For This Newly Listed Norovirus Vaccine

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target. The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity. It estimates $625 million in risk-adjusted infant HIL214 sales in 2030E ($1 billion unadjusted). The outlook is supported by…

Benzinga

Read Why Magnachip Shares Are Trading Higher Today

LX Group collaborated with the Carlyle Group private equity fund manager to propose a takeover offer for Magnachip Semiconductor Corp (NYSE:MX), a media reported. LX Group recently submitted a letter of intent to acquire Magnachip Semiconductor to JP Morgan in the United States. The industry valued Magnachip at $1.2 billion (1.5 trillion won). Also Read: Magnachip…

Benzinga

How Does Grupo Somar Acquisition Reaffirms Procaps' Strategy To Strengthen Footprint In LatAm

Integrated LatAm healthcare and pharmaceutical company Procaps Group (NASDAQ:PROC) has agreed to acquire Grupo Somar (including Grupo Farmacéutico Somar, Química y Farmacia, Gelcaps, and related entities) from Advent International, private equity. Deal terms were not disclosed. Grupo Somar is focused on developing, manufacturing, and marketing branded generic, private label, and OTC products targeted to…

Benzinga

41 Stocks Moving In Monday's Mid-Day Session

Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022

Upgrades

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Is Comstock Resources a Good Oil & Gas Stock to Own in 2022?

Shares of oil and gas exploration company Comstock Resources (CRK) have rallied nearly 160% in price over the past year on the back of surging energy prices. However, given that JP Morgan recently cut its global oil demand forecast for 2022, would it be worth adding the stock to one’s…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022

Upgrades

Bangkok Post

JP Morgan downgrades Thailand on fading tourism recovery

Analysts at J.P. Morgan downgraded Thailand's equities rating on Monday, citing the slow pace of recovery in the tourism industry due to rising inflation and a surge in Covid-19 cases in China.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022

Benzinga

JP Morgan Upgrades Ecolab: Here's What You Need To Know

JP Morgan upgraded its rating of Ecolab (NYSE:ECL) to Overweight with a price target of $190.00, changing its price target from $191.00 to $190.00. Shares of Ecolab are trading up 1.77% over the last 24 hours, at $171.46 per share.

Benzinga

This Is What Whales Are Betting On Tesla

A whale with a lot of money to spend has taken a noticeably bearish stance on Tesla. Looking at options history for Tesla (NASDAQ:TSLA) we detected 414 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.